Gallbladder disease among obese patients in Taiwan

Obesity Surgery

Volumn 17, Issue 3, 2007, Pages 383-390

  Liew, Phui Ly ^a   Wang, Weu ^b   Lee, Yi Chih ^c   Huang, Ming Te ^b   Lin, Yang Chu ^d   Lee, Wei Jei ^e,f  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d SOOCHOW UNIVERSITY   (Taiwan)

^e MIN SHENG GENERAL HOSPITAL   (Taiwan)

^f Department of Surgery ^*  (Taiwan)

Author keywords

Gallbladder disease; Helicobacter pylori; Histopathology; Morbid obesity

Indexed keywords

BACTERIUM ANTIBODY; C REACTIVE PROTEIN; CALCIUM; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGE DISTRIBUTION; ANTIBODY DETECTION; ARTICLE; BARIATRIC SURGERY; BODY MASS; CELL INFILTRATION; CHOLELITHIASIS; CHOLESTEROL POLYP; CHOLESTEROSIS; CHRONIC INFLAMMATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GALLBLADDER DISEASE; GALLBLADDER MUCOSA; GASTROINTESTINAL DISEASE; HELICOBACTER PYLORI; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; LABORATORY TEST; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METAPLASIA; MONONUCLEAR CELL; MULTIVARIATE ANALYSIS; OBESITY; POLYP; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEROPREVALENCE; STOMACH DISEASE; TAIWAN; WAIST CIRCUMFERENCE;

ADULT; CHOLECYSTITIS; CHOLECYSTOLITHIASIS; CHRONIC DISEASE; COMORBIDITY; FEMALE; GALLBLADDER DISEASES; HEPATITIS B SURFACE ANTIGENS; HUMANS; MALE; OBESITY; OBESITY, MORBID; PREVALENCE; RETROSPECTIVE MORAL JUDGMENT; TAIWAN;

EID: 34247485735     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-007-9068-4     Document Type: Article

References (35)

1. Kodama H, Kono S, Todoroki I et al. Gallstone disease risk in relation to body mass index and waist-tohip ratio in Japanese men. Int J Obes 1999; 23: 211-6.
2. Aidonopouios AP, Papavramidis ST, Zaraboukas TG et al. Gallbladder findings after cholecystectomy in morbidly obese patients. Obes Surg 1994; 4: 8-12.
3. Calhoun R, Willbanks O. Coexistence of gallbladder disease and morbid obesity. Am J Surg 1987; 154: 655-8.
4. Fobi M, Lee H, Igwe D et al. Prophylactic cholecystectomy with gastric bypass operation: incidence of gallbladder disease. Obes Surg 2002; 12: 350-3.
5. Hamad GG, Ikramuddin S, Gourash WF et al. Elective cholecystectomy during laparoscopic rouxen-y gastric bypass: is it worth the wait? Obes Surg 2003; 13: 76-81.
6. Liem RK, Niloff PH. Prophylactic cholecystectomy with open gastric bypass operation. Obes Surg 2004; 14: 763-5.
7. Guadalajara H, Baro RS, Pascual I et al. Is prophylactic cholecystectomy useful in obese patients undergoing gastric bypass? Obes Surg 2006; 16: 883-5.
8. Dittrick GW, Thompson JS, Campos D et al. Gallbladder pathology in morbid obesity. Obes Surg 2005; 15: 238-42.
9. Csendes A, Smok G, Burdiles P et al. Histological findings of gallbladder mucosa in 95 control subjects and 80 patients with asymptomatic gallstones. Dig Dis Sci 1998; 43: 931-4.
10. Csendes A, Burdiles P, Smok G et al. Histologic findings of gallbladder mucosa in 87 patients with morbid obesity without gallstones compared to 87 control subjects. J Gastrointest Surg 2003; 7: 547-51.
11. Lu S-N, Chang W-Y, Wang L-Y et al. Risk factors for gallstones among chinese in taiwan. J Clin Gastroenterol 1990; 12: 542-6.
12. Fox JG, Dewhirst FE, Shen Z et al. Hepatic Helicobacter species identified in bile and gallbladder tissue from chileans with chronic cholecystitis. Gastroenterol 1998; 114: 755-63.
13. Lin T-T, Yeh C-T, Wu C-S et al. Detection and partial sequence analysis of helicobacter pylori dna in the bile samples. Dig Dis Sci 1995; 40: 2214-9.
14. Neri V, Margiotta M, Francesco VD et al. Dna sequences and proteic antigens of H. Pylori in cholecystic bile and tissue of patients with gallstones. Aliment Pharmacol Ther 2005; 22: 715-20.
15. Mendez-Sanchez N, Pichardo R, Gonzalez J et al. Lack of association between helicobacter sp colonization and gallstone disease. J Clin Gastroenterol 2001; 32: 138-41.
16. Chen W, Li D, Cannan RJ et al. Common presence of Helicobacter DNA in the gallbladder of patients with gallstone diseases and controls. Dig Liver Dis 2003; 35: 237-43.
17. Maurer KJ, Rogers AB, Ge Z et al. Helicobacter pylori and cholesterol gallstone formation in c57l/j mice: a prospective study. Am J Physiol Gastrointest Liver Physiol 2006; 290: G175-82.
18. Myung S-J, Kim M-H, Shim KN et al. Detection of Helicobacter pylori DNA in human biliary tree and its association with hepatolithiasis. Dig Dis Sci 2000; 45: 1405-12.
19. Arnaout AH, Abbas SH, Shousha S. Helicobacter pylori is not identified in areas of gastric metaplasia of gallbladder. J Pathol 1990; 160: 333-4.
20. Leong RWL, Sung JJY. Helicobacter species and hepatobiliary diseases. Aliment Pharmacol Ther 2002; 16: 1037-45.
21. Wu M-S, Lee W-J, Wang H-H et al. A case-control study of association of Helicobacter pylori infection with morbid obesity in taiwan. Arch Intern Med 2005; 165:1552-5.
22. Lee W-J, Wang W. Bariatric surgery: Asia-Pacific perspective. Obes Surg 2005; 15: 751-7.
23. Dixon JB, O'Brien PE. Obesity and the white blood cell count: changes with sustained weight loss. Obes Surg 2006; 16: 251-7.
24. Ziccardi P, Nappo F, Giugliano G et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105: 804-9.
25. Mendez-Sanchez N, Bahena-Aponte J, Chavez-Tapia NC et al. Strong association between gallstones and cardiovascular disease. Am J Gastroenterol 2005; 100: 827-30.
26. Nervi F, Miquel JF, Alvarez M et al. Gallbladder disease is associated with insulin resistance in a high risk hispanic population. J Hepatology 2006; 45: 299-305.
27. Sheen I-S, Liaw Y-F. Hepatology 1989; 9: 538-40.
28. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in severely obese. Gastroenterology 2001; 121: 91-100.
29. Loria P, Lonardo A, Lombardini S et al. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors. J Gastroenterol Hepatol 2005; 20: 1176-84.
30. Deitel M, Petrov I. Incidence of symptomatic gallstones after bariatric operations. Surg Gynecol Obstet 1987; 164: 549-52.
31. Seinige UL, Sataloff DH, Lieber CP et al. Gallbladder disease in the morbidly obese patient. Obes Surg 1991; 1: 51-6.
32. Kiewiet RM, Durian MF, Leersum M: gallstone formation after weight loss following gastric banding in morbidly obese dutch patients. Obes Surg 2006; 16: 592-96.
33. Oria HE. Pitfalls in the diagnosis of gallbladder disease in clinically severe obesity. Obes Surg 1998; 8: 444-51.
34. Mason EE, Renquist KE, IBSR Data Contributors. Gallbladder management in obesity surgery. Obes Surg 2002; 12: 222-9.
35. O'Brien PE, Dixon JB. A rational approach to cholelithiasis in bariatric surgery. Arch Surg 2003; 138: 908-12.